Settlement Structure: Claims Made
Closed Settlement Statement:
According to court documents, the claim submission deadline has passed. Please contact the claims administrator if you have any questions.Case Summary:
Infinity Diagnostics Laboratory, Inc. is settling a class action concerning a finger-stick antibody blood test for Covid-19 that was provided in New Jersey. The complaint alleges that Infinity fraudulently presented the tests as rapid blood tests capable of diagnosing active cases of Covid-19 when in fact they were not capable of doing so.Docket Number:
Company: Infinity Diagnostics Laboratory, Inc.
Filing Deadline: February 12, 2022
Class Period: March 1, 2020
Objection Deadline: December 31, 2021
Exclusion Deadline: December 31, 2021
Final Approval Hearing: January 21, 2022Proof of Purchase:
You do not need to provide proof but will be eligible for a larger cash benefit if you do so.Eligibility:
You may be eligible if you are a citizen of New Jersey who bought a finger-stick antibody blood test for Covid-19 that was administered and sold by Infinity or its employees in New Jersey, between March 1, 2020 and the present.Typical Settlement Amount:
Cash benefit. With proof of test: $75. Without proof: Up to $37.50, with final amount depending on number of valid claims made.
Total Settlement Amount: $130,000Class Representative Proposed Incentive Fee:
Denittis Osefchen PC
Case Name: Arabia, et al. v. Infinity Diagnostics Laboratory, Inc.
Settlement Website: Infinity Diagnostics Covid-19 Antibody Test Settlement Website
Infinity Class Settlement
c/o Infinity Claims Administrator
1650 Arch Street, Suite 2210
Philadelphia, PA 19103